Experiments in mouse models of lymphoma, sarcoma, and hepatocarcinoma indicate that targeting p53 may be a sensible therapeutic strategy and that cellular senescence contributes to tumor regression.
No takes yet. Share an insight, caveat, or question.
Manuel Serrano (2007) studied this question.